Qsar study of some substituted 4-quinolinyl and 9-acridinyl hydrazones as antimalarial agents.

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Acta Poloniae Pharmaceutica - Drug Research

• Publication date

  2012-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 23285677
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A novel QSAR model for predicting the inhibition of CXCR3 receptor by 4-N-aryl-[1,4] diazepane ureas.

  2009cited by this paper
• Topological descriptors in modelling antimalarial activity: N(1)-(7-chloro-4-quinolyl)-1,4-bis(3-aminopropyl)piperazine as prototype.

  2009cited by this paper
• Design, synthesis, and structure-activity relationship studies of 4-quinolinyl- and 9-acrydinylhydrazones as potent antimalarial agents.

  2008cited by this paper
• Novel Molecular Targets for Antimalarial Drug Development

  2008cited by this paper
• A study on antimalarial artemisinin derivatives using MEP maps and multivariate QSAR

  2008cited by this paper
• Modelling and informatics in the analysis of P. falciparum DHFR enzyme inhibitors.

  2008cited by this paper
• An in silico 3D pharmacophore model of chalcones useful in the design of novel antimalarial agents.

  2007cited by this paper
• Synthesis of N1-arylidene-N2-quinolyl- and N2-acrydinylhydrazones as potent antimalarial agents active against CQ-resistant P. falciparum strains.

  2006cited by this paper
• Antimalarial activity: a QSAR modeling using CODESSA PRO software.

  2006cited by this paper
• QSAR for anti-malarial activity of 2-aziridinyl and 2,3-bis(aziridinyl)-1,4-naphthoquinonyl sulfonate and acylate derivatives

  2006cited by this paper
• Mapping antimalarial pharmacophores as a useful tool for the rapid discovery of drugs effective in vivo: design, construction, characterization, and pharmacology of metaquine.

  2005cited by this paper
• A three-dimensional in silico pharmacophore model for inhibition of Plasmodium falciparum cyclin-dependent kinases and discovery of different classes of novel Pfmrk specific inhibitors.

  2004cited by this paper
• Protein farnesyl and N-myristoyl transferases: piggy-back medicinal chemistry targets for the development of antitrypanosomatid and antimalarial therapeutics.

  2003cited by this paper
• QSAR Modeling Using Chirality Descriptors Derived from Molecular Topology

  2003cited by this paper
• Beware of q2!

  2002cited by this paper
• Chem-bioinformatics and QSAR: a review of QSAR lacking positive hydrophobic terms.

  2001cited by this paper
• Technical report series

  1989cited by this paper
• Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins.

  1988cited by this paper

• Hybrid Inorganic Complexes as Cancer Therapeutic Agents: In-vitro Validation

  2023cites this paper
• SYNTHESIS AND ANTIMICROBIAL ACTIVITY OF SOME SUBSTITUTED 2-PYRAZOLINES SULPHONAMIDE HYBRID COMPOUNDS

  2020cites this paper
• Novel fluorine-containing chiral hydrazide-hydrazones: Design, synthesis, structural elucidation, antioxidant and anticholinesterase activity, and in silico studies.

  2019cites this paper
• Quantitative Structural Activity Relationship of Hydrazide Derivatives of Loratadine: A Combined Density Functional Theory and In Silico Study

  2019cites this paper
• Ensemble-based modeling of chemical compounds with antimalarial activity.

  2019cites this paper
• Synthesis, Characterization and In-Silico ADMET Screening of Mono- and Dicarbomethoxylated6,6'-Methylenebis(2-cyclohexyl-4-methylphenol) and TheirHydrazides and Hydrazones

  2017cites this paper
• QSAR STUDY OF ANTIMALARIA OF XANTHONE DERIVATIVES USING MULTIPLE LINEAR REGRESSION METHODS

  2016cites this paper
• The current status of antimalarial drug research with special reference to application of QSAR models.

  2015cites this paper